Mucosal Immune Checkpoints in Chronic Bacterial Cystitis
Mucosal Immune Checkpoints in Chronic Bacterial Cystitis
批准号:
7712858
负责人:
THOMAS Joseph HANNAN
金额:
$11.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2012-07-31
关键词:
AcuteAddressAdolescentAdultAffectAgeAllergicAntibiotic TherapyAntibodiesBacteriaBacteriuriaBiological AssayBladderBone MarrowC3H/HeN MouseCellsChronicChronic CystitisChronic Inflammatory InfiltrateClinicalCollaborationsColony-Stimulating FactorsCommunicable DiseasesCore FacilityCystitisDevelopmentDiseaseDisease OutcomeDoctor of PhilosophyEpitheliumEscherichia coli InfectionsEtiologyFaceFellowshipFlow CytometryGranulocyte Colony-Stimulating FactorGrowth and Development functionHealth Care CostsHost DefenseHourHumanIL8 geneImmuneImmune responseImmunodeficient MouseImmunoglobulinsImmunologyInbred C3H MiceInfectionInfectious Diseases ResearchInfective cystitisInflammationInflammatoryInflammatory ResponseInstitutionInstructionInterleukin-5Interleukin-6JointsK-Series Research Career ProgramsKidneyKineticsKnowledgeLeftLower urinary tractLymphocyteLymphoid FollicleMarriageMediatingMentorsMentorshipMicrobiologyModelingMolecularMouse StrainsMusNatureOutcomePathogenesisPathologyPostdoctoral FellowPrevalencePrincipal InvestigatorProductionPyuriaReactionRecording of previous eventsRecurrenceReporterResearchResearch PersonnelResearch ProposalsResistanceResolutionRespiratory BurstRoleSerumSignal TransductionSiteStaining methodStainsSuspension substanceSuspensionsT-LymphocyteTechnical ExpertiseTestingTherapeuticTissuesTrainingTransgenic OrganismsUnited StatesUniversitiesUrinary tractUrinary tract infectionUropathogenic E. coliUrotheliumWashingtonWorkanalogbasecostcytokinegranulocyteimmune functioninterestkeratinocytekillingsloss of functionmast cellmouse modelneutrophilpathogenprophylacticresearch studyresponsetherapeutic vaccine
中文摘要
描述(由申请人提供):在此申请中,我要求职业发展奖支持研究“慢性细菌性膀胱炎的粘膜免疫检查点”。我将与我的共同导师Marco Colonna和Scott Hultgren合作开展这项工作,他们都在华盛顿大学。这些免疫学和微生物学领域的专家的结合将作为一个伟大的指导团队,因为我开始了这个联合博士后奖学金。这次合作源于我对慢性细菌性膀胱炎小鼠模型的兴趣。尿路感染(UTI)是一种常见、昂贵且经常复发的疾病。尿路致病性大肠杆菌(UPEC)是尿路感染最常见的原因。UPEC引发宿主防御以应对殖民化。了解宿主反应在这种疾病中的作用对我们开发有效疫苗和治疗方法的能力至关重要。我们发现幼年C3H/HeN小鼠对UPEC感染有两种不同的反应:要么在2周内消除感染,要么发展为持续至少7个月的慢性膀胱炎。此外,慢性膀胱炎的发展与更严重的急性宿主反应密切相关。这种类似过敏的反应,在其他研究的小鼠品系中未见,构成了本研究假设的基础,即在慢性膀胱炎发展之前存在一个被触发的宿主检查点。本研究将通过研究该检查点的细胞和分子机制以及检验因果关系来验证这一假设。在我解决这些难题的过程中,科隆纳博士将在这个项目中提供指导、知识和技术专长。Hultgren博士将在传染病研究和尿路感染小鼠模型领域提供指导和专业知识。华盛顿大学是一个从事科学研究的好地方,拥有众多的支持和核心设施。在2003年离开临床兽医实践后,我开始跟随Hultgren博士进行博士培训,并于2008年8月获得微生物学博士学位。在研究生工作结束时,我对宿主对感染的反应产生了兴趣,并决定攻读免疫学博士后,以扩大我在传染病机制方面的专业知识。我希望在一个学术研究机构工作,作为一个独立的调查员,研究宿主-病原体的相互作用。相关性(见说明书):尿路感染(UTI)是一个主要问题:它们是常见的,昂贵的,并且经常复发或慢性。我们建立了一种慢性尿路感染的小鼠尿路致病性大肠杆菌模型,发现慢性感染的发展与感染早期的过敏样膀胱反应有关。发生这种反应后,这些小鼠容易复发尿路感染,这为人类复发尿路感染提供了可能的解释。
英文摘要
DESCRIPTION (provided by applicant): In this application, I am requesting career development award support to investigate "Mucosal Immune Checkpoints in Chronic Bacterial Cystitis." I will be undertaking this work in collaboration with my co-mentors, Marco Colonna and Scott Hultgren, both here at Washington University. This marriage of these experts in the fields of Immunology and Microbiology will serve as a great mentoring team as I embark on this joint post- doctoral fellowship. This collaboration arose out of my interest in a murine model of chronic bacterial cystitis. Urinary tract infections (UTI) are common, costly, and very often recurrent. Uropathogenic E. coli (UPEC) are the most common cause of UTI. UPEC elicit host defenses in response to colonization. Understanding the role of the host response in this disease is critical for our ability to develop effective vaccines and therapeutics. We have found that juvenile C3H/HeN mice have two distinct responses to UPEC infection: either they resolve infection within 2 weeks or they develop chronic cystitis that lasts for at least 7 months. Furthermore, development of chronic cystitis strongly correlates with a significantly more severe acute host response. This allergic-like response, which is not seen in other mouse strains studied, forms the basis for the hypothesis of this study, which is that there is a host checkpoint that is being triggered prior to the development of chronic cystitis. This study will test this hypothesis by investigate the cellular and molecular mechanism of this checkpoint and testing for causality. Dr. Colonna will be providing mentorship, knowledge and technical expertise during this project as I address these difficult questions. Dr. Hultgren will be providing mentorship and expertise in the field of infectious disease research and the murine model of UTI. Washington University is a wonderful place to pursue scientific research, with numerous support and core facilities. Upon leaving clinical veterinary practice in 2003, I began my doctoral training with Dr. Hultgren and graduated with a Ph.D. in Microbiology in August, 2008. I became interested in host responses to infection towards the end of my graduate work and decided to pursue a post-doctoral fellowship in Immunology to broaden my expertise in mechanisms of infectious disease. I hope to work at an academic research institution as an independent investigator studying the host-pathogen interaction. RELEVANCE (See instructions): Urinary tract infections (UTI) are a major problem: they are common, costly, and often recurrent or chronic. We have developed a mouse model of chronic urinary tract infection with the bacterium uropathogenic E. coli, and found that development of chronic infection is associated with an allergic-like bladder response early in infection. After having this reaction, these mice are prone to recurrent UTI, providing a possible explanation for recurrent UTI in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
-
批准号:10698829
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2023
-
负责人:THOMAS Joseph HANNAN
-
依托单位:
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
-
批准号:10385057
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2019
-
负责人:THOMAS Joseph HANNAN
-
依托单位:
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
-
批准号:9906022
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2019
-
负责人:THOMAS Joseph HANNAN
-
依托单位:
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
-
批准号:10536683
-
项目类别:
-
资助金额:$99.79万
-
财政年份:2019
-
负责人:THOMAS Joseph HANNAN
-
依托单位:
Mucosal Immune Checkpoints in Chronic Bacterial Cystitis
-
批准号:7924552
-
项目类别:
-
资助金额:$11.86万
-
财政年份:2009
-
负责人:THOMAS Joseph HANNAN
-
依托单位:
Mucosal Immune Checkpoints in Chronic Bacterial Cystitis
-
批准号:8115921
-
项目类别:
-
资助金额:$12.14万
-
财政年份:2009
-
负责人:THOMAS Joseph HANNAN
-
依托单位:
海外基金